ObjectiveHealth, a leading clinical research site network backed by Vitruvian Partners, has acquired Piedmont Research Partners (PRP), a premier site in Indian Land, SC. This strategic acquisition strengthens ObjectiveHealth’s mission to accelerate clinical trials and improve patient outcomes through its embedded research model and proprietary platforms—ObjectiveScreen, for advanced patient identification and pre-screening, and ObjectiveView, for operational excellence and real-time performance monitoring. PRP adds 15 years of expertise in Phase II–IV trials across Cardiology, Endocrinology, Rheumatology, GI, and Immunology, expanding ObjectiveHealth’s therapeutic reach and scalability.
Read the full article: ObjectiveHealth Expands Clinical Research Network with Acquisition of Piedmont Research Partners //
Source: https://www.prweb.com/releases/objectivehealth-expands-clinical-research-network-with-acquisition-of-piedmont-research-partners-302641920.html